CLAFORAN - PWS INJ 1.0G/VIAL DIN 02225093
Health Canada record
| Active ingredient(s) | CEFOTAXIME SODIUM 1 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DD01 CEFOTAXIME |
| Original market date | 10-Oct-2003 |
| Current status date | 24-Nov-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFOTAXIME SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02352176 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | CEFOTAXIME SODIUM 1 G | Approved |
| 02352184 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | CEFOTAXIME SODIUM 2 G | Approved |
| 02352168 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | CEFOTAXIME SODIUM 0.5 G | Approved |
| 02434105 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | CEFOTAXIME SODIUM 2 G | Marketed |
| 02434083 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | CEFOTAXIME SODIUM 500 MG | Approved |
| 02434091 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | CEFOTAXIME SODIUM 1 G | Marketed |
| 02225107 | CLAFORAN - PWS INJ 2.0G/VIAL | SANOFI-AVENTIS CANADA INC | Powder For Solution | CEFOTAXIME SODIUM 2 G | Cancelled Post Market |
| 02225085 | CLAFORAN - PWS INJ 500MG/VIAL | SANOFI-AVENTIS CANADA INC | Powder For Solution | CEFOTAXIME SODIUM 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7838 | 2006-03-21 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1048 | 2000-06-12 | New Drug Submission (NDS) | |
| 4300 | 1996-07-17 | New Drug Submission (NDS) |
International API supply for CEFOTAXIME SODIUM
0 valid EDQM Certificates of Suitability from 0 holders. 5 active FDA Drug Master Files.
Request a quote for CLAFORAN - PWS INJ 1.0G/VIAL